113 results
Page 5 of 6
424B5
wfm6me
16 Apr 20
Prospectus supplement for primary offering
8:44am
8-K
EX-99.1
h4rkg
3 Dec 19
Regulation FD Disclosure
8:00am
8-K
EX-99.1
guviyyee5xz2jzdv
6 Nov 19
Aeglea BioTherapeutics Reports Third Quarter 2019 Financial Results and Corporate Highlights
8:30am
8-K
EX-99.2
jetfl q158
3 Sep 19
Aeglea BioTherapeutics Announces Positive 20-Dose Data for Pegzilarginase in Patients with Arginase 1 Deficiency at the 2019 SSIEM Symposium
6:03am
8-K
EX-99.1
rac31cg3rscmmur1z
3 Sep 19
Aeglea BioTherapeutics Announces Positive 20-Dose Data for Pegzilarginase in Patients with Arginase 1 Deficiency at the 2019 SSIEM Symposium
6:03am
8-K
EX-99.3
imbw1e23yudd
3 Sep 19
Aeglea BioTherapeutics Announces Positive 20-Dose Data for Pegzilarginase in Patients with Arginase 1 Deficiency at the 2019 SSIEM Symposium
6:03am
8-K
EX-99.4
01h22ql6hiv0qugy33m
3 Sep 19
Aeglea BioTherapeutics Announces Positive 20-Dose Data for Pegzilarginase in Patients with Arginase 1 Deficiency at the 2019 SSIEM Symposium
6:03am
8-K
maayq1wrdjy
3 Sep 19
Aeglea BioTherapeutics Announces Positive 20-Dose Data for Pegzilarginase in Patients with Arginase 1 Deficiency at the 2019 SSIEM Symposium
6:03am
8-K
EX-99.2
cxw ybrg3o
8 Apr 19
Regulation FD Disclosure
6:05am
8-K
EX-99.3
7shx20 zufw1pm
8 Apr 19
Regulation FD Disclosure
6:05am
8-K
EX-99.1
xdlzq1jc2 jtet00y
11 Dec 18
Aeglea BioTherapeutics Announces Design of Pivotal Phase 3 PEACE Trial Evaluating Pegzilarginase in Arginase 1 Deficiency
4:05pm